The American Diabetes Association Announces New Editors for Diabetes Care
August 15, 2011
The American Diabetes Association announces the appointment of William T. Cefalu, MD, of the Pennington Biomedical Research Center and the Louisiana State University Health Science Center (LSUHSC) School of Medicine, as the Editor-in-Chief of Diabetes Care. Diabetes Care is the Association’s premier peer-reviewed journal dedicated to diabetes care, prevention, and treatment.
The Association also announced the appointment of the following Associate Editors to the editorial team of Diabetes Care:
• George Bakris, MD, University of Chicago Medical Center
• Lawrence Blonde, MD, FACP, Ochsner Clinic and Alton Ochsner Medical Foundation
• Andrew J. M. Boulton, MD, University of Manchester and the University of Miami
• Mary de Groot, PhD, Indiana University School of Medicine
• Eddie L. Greene, MD, Mayo Clinic
• R. Robert Henry, MD, VA San Diego Healthcare System and the University of California, San Diego
• Sherita Hill Golden, MD, MHS, FAHA, Johns Hopkins University
• Frank Hu, MD, MPH, PhD, Harvard School of Public Health
• Derek LeRoith, MD, PhD, Mount Sinai School of Medicine
• Robert G. Moses, MD, South Eastern Sydney & Illawarra Area Health Service
• Eric Ravussin, PhD, Pennington Biomedical Research Center
• Stephen Rich, PhD, University of Virginia
• Matthew C. Riddle, MD, Oregon Health & Science University
• Julio Rosenstock, MD, Dallas Diabetes and Endocrine Center
• William V. Tamborlane, MD, Yale Center for Clinical Investigation
• Katie Weinger, EdD, RN, Joslin Diabetes Center
• Judith Wylie-Rosett, EdD, RD, Albert Einstein College of Medicine
The team will serve a three-year term, for the 2012 to 2014 volume years, with an optional two-year extension.
As the incoming Editor-in-Chief of Diabetes Care, Cefalu brings a wealth of professional and scholarly experience to the journal. Cefalu is Director of the Joint Diabetes, Endocrinology and Metabolism Program of the LSUHSC School of Medicine and Pennington Biomedical Research Center, as well as the Douglass L. Manship Sr., Professor of Diabetes at Pennington Biomedical Research Center.
The American Diabetes Association, the Pennington Biomedical Research Center, and the LSUHSC are proud to come together to support Cefalu and the publication of high-impact diabetes-related research in Diabetes Care.
“The appointment of Dr. Cefalu brings great honor to the Pennington Biomedical Research Center,” said Steven Heymsfield, MD, Executive Director. “The peer-reviewed Diabetes Care will continue under his editorship to provide timely, insightful, in-depth information on this profoundly important health topic.”
Likewise, Steve Nelson, MD, Dean of the LSUHSC School of Medicine, applauds the appointment of Cefalu as the next Editor-in-Chief of Diabetes Care. “This is well-deserved recognition for the stature that Dr. Cefalu has attained professionally. He is an accomplished physician scientist. We are proud to have him on our LSU School of Medicine faculty and honored that our school will be working closely with the American Diabetes Association in the dissemination of the latest in research findings for the care of patients with diabetes.”
Cefalu’s research is active at both the clinical and basic levels. On a clinical level, he is interested in clinical interventions to improve the metabolic state of individuals with insulin resistance and type 2 diabetes. On a basic level, he is interested in cellular mechanisms for insulin resistance. In addition, Cefalu also serves as Director for a National Institutes of Health-funded Center for the Study of Botanicals and Metabolic Syndrome at Pennington Biomedical Research Center.
Cefalu has published widely in journals, books, and book chapters and has edited several textbooks on the management of diabetes. He is a past Associate Editor for Diabetes Care and is currently an Associate Editor for Diabetes. He lectures both nationally and internationally.
Cefalu and his editorial team will succeed current Editor-in-Chief Vivian A. Fonseca, MD, and his current editorial team, which convened in July 2006 and will complete its tern at the end of 2011:
• Edward J. Boyko, MD
• Antonio Ceriello, MD
• Charles M. Clark, Jr., MD
• Samuel Dagogo-Jack, MD, FRCP
• Lawrence Fisher, PhD
• Todd P. Gilmer, PhD
• Carla J. Greenbaum, MD
• James B. Meigs, MD, MPH
• Richard E. Pratley, MD
• Aaron I. Vinik, MD
• Ruth S. Weinstock, MD, MPH
• Bernard Zinman, MD
Current Associate Editors Andrew M. Boulton, MD; Robert G. Moses, MD; Katie Weinger, EDD, RN; and Judith Wylie-Rosset, EDD, RD, will continue with Cefalu’s team.
“My colleagues and I are extremely excited to oversee the future editorial direction of Diabetes Care, the top clinical journal for diabetes care and management in the world,” stated Cefalu. “Our goal is to ensure the journal continues to address the changing health care and research landscape, as well as provide health care professionals with the information they need to better manage people with diabetes.”
Diabetes Care is the highest-ranked journal devoted exclusively to diabetes prevention and treatment. The journal publishes original research about topics that are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals. Diabetes Care is published 12 times a year and is received by American Diabetes Association Category I Professional Members.
More information about Diabetes Care can be found at http://diabetes.org/diabetescare.
About the American Diabetes Association
Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)